Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Ducret

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Journal of Biological Response Modifiers|April 1, 1985
A phase I clinical tolerance study of polyadenylic-polyuridylic acid in cancer patientsJ P Ducret, P Caillé, H Sancho Garnier, et al.
Anticancer Research|September 1, 1986
Preliminary phase I clinical study and pharmacokinetics of (1,2-diaminocyclohexane) (isocitrato) platinum (II) or PHICA Gouyette, J P Ducret, P Caillé, et al.
Pediatric Research|February 1, 1996
Follow-up of three years of treatment with growth hormone and of one post-treatment year, in children with severe growth retardation of intrauterine onsetJ C Job, J L Chaussain, B Job, et al.
Cancer Treatment Reports|July 1, 1985
Phase II trial of elliptinium in advanced renal cell carcinomaP Caillé, J M Mondesir, J P Droz, et al.
Presse Medicale (Paris, France : 1983)|June 16, 1984
[Treatment of metastatic renal cancer in adults with elliptinium acetate]J L Amiel, J Rouessé, J P Droz, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Journal of Biological Response Modifiers|April 1, 1985
A phase I clinical tolerance study of polyadenylic-polyuridylic acid in cancer patientsJ P Ducret, P Caillé, H Sancho Garnier, et al.
Anticancer Research|September 1, 1986
Preliminary phase I clinical study and pharmacokinetics of (1,2-diaminocyclohexane) (isocitrato) platinum (II) or PHICA Gouyette, J P Ducret, P Caillé, et al.
Pediatric Research|February 1, 1996
Follow-up of three years of treatment with growth hormone and of one post-treatment year, in children with severe growth retardation of intrauterine onsetJ C Job, J L Chaussain, B Job, et al.
Cancer Treatment Reports|July 1, 1985
Phase II trial of elliptinium in advanced renal cell carcinomaP Caillé, J M Mondesir, J P Droz, et al.
Presse Medicale (Paris, France : 1983)|June 16, 1984
[Treatment of metastatic renal cancer in adults with elliptinium acetate]J L Amiel, J Rouessé, J P Droz, et al.
Pageof 2